Taubert, company group chairman of The Americas Pharmaceuticals at Johnson & Johnson, shares what it meant to be named to Fortune’s annual list.
By Sheila Weller
When Fortune‘s 2016 Most Powerful Women list was released recently, there were nine first-timers on the roster, including Jennifer Taubert, company group chairman of The Americas Pharmaceuticals at Johnson & Johnson (No. 8 on the DiversityInc Top 50 Companies list).
In a nutshell, she’s tasked with overseeing and leading the growth of existing and new business in Canada, the United States and Latin America, and creating innovation along the way.
In honor of her inaugural year as a Fortune Most Powerful Woman, we sat down with Taubert to find out what it felt like to be recognized, what inspires her high-profile workand what she plans to accomplish from here.
“Part of the fun of working in healthcare is the next discovery is literally around the corner. Our work is never done, and that keeps it exciting.”
Q: What are you proudest of having accomplished at Johnson & Johnson in the past year
A: I am really proud that, in the last year, we were able to help 15 million people throughout the Americas with our products because patients really are at the center of all that we do. One special product we were able to launch in the last 18 months is Darzalex, for the treatment of multiple myeloma. It received two breakthrough therapy designations from the FDA, based on the significance of the innovation, coupled with the level of unmet medical need that there is for the treatment.
We developed, got FDA approval for, and launched Darzalex in truly record time to get it to the patients who need it. It was a real source of pride for us.
Mentoring is something that is also really important to me. I’ve provided advice and guidance to some remarkable young women through the Fortune/U.S. State Department Global Women’s Mentoring Partnership. And even though I am mentoring them, I learn and get just as much out of it as they do.